Psoriasis

• FDA approval · 2018-03-15
  FDA Approved: METHOTREXATE — Supplemental Application (Hospira, Inc.)

  FDA approved a supplemental application for Methotrexate submitted by Hospira, Inc.

• FDA approval · 2018-02-13
  FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Encube Ethicals, Inc.)

  FDA approved Betamethasone Dipropionate as an original application from Encube Ethicals, Inc. (ANDA206389) for topical use in inflammatory d…

• FDA approval · 2017-11-21
  FDA Approved: HYDROCORTISONE BUTYRATE — Original Application (The J. Molner Company LLC)

  The FDA approved a generic topical hydrocortisone butyrate product under an Original Application (ANDA 209556) from The J. Molner Company LL…

• FDA approval · 2017-10-27
  FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Pharmaceuticals USA Inc.)

  FDA approved the original ANDA for a generic clobetasol propionate topical product from Zydus Pharmaceuticals USA Inc.

• FDA approval · 2017-10-13
  FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)

  The FDA approved a supplemental application for ustekinumab (Stelara) from Janssen Biotech, Inc., potentially expanding indications or updat…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2017-09-19
  FDA Approved: DESOXIMETASONE — Original Application (Viona Pharmaceuticals Inc)

  FDA approved Desoximetasone from Viona Pharmaceuticals Inc via an Original Application (ANDA205206).

• FDA approval · 2017-07-21
  FDA Approved: FLUOCINONIDE — Original Application (Novel Laboratories, Inc.)

  FDA approval for fluocinonide from Novel Laboratories, Inc. as an Original Application (ANDA), representing first-time approval of this gene…

• FDA approval · 2017-07-17
  FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

  The FDA approved Padagis Israel Pharmaceuticals Ltd's generic fluocinonide acetonide as an original application (ANDA 202849) for topical tr…

• FDA approval · 2017-05-26
  FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for betamethasone dipropionate from Sun Pharmaceutical Industries, Inc., authorizing an update to th…

• FDA approval · 2017-05-24
  FDA Approved: BETAMETHASONE VALERATE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved Sun Pharmaceutical Industries, Inc.'s original generic application for Betamethasone valerate. This approval makes the generic …

• FDA approval · 2017-05-11
  FDA Approved: ACITRETIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  FDA approves a supplemental application for Acitretin from Amneal Pharmaceuticals of New York LLC (ANDA 202552).

• FDA approval · 2017-03-07
  FDA Approved: METHOTREXATE — Supplemental Application (Fresenius Kabi USA, LLC)

  The FDA approved a supplemental application for METHOTREXATE SODIUM from Fresenius Kabi USA, LLC.

• FDA approval · 2017-02-16
  FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Lifesciences Limited)

  FDA approved the original ANDA for clobetasol propionate topical corticosteroid from Zydus Lifesciences Limited.

• FDA approval · 2017-01-12
  FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Cosette Pharmaceuticals, Inc.)

  FDA approves Cosette Pharmaceuticals' original ANDA for Triamcinolone Acetonide topical (generic), clearing a new generic product on the mar…

• FDA approval · 2017-01-11
  FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)

  FDA approved Lupin Pharmaceuticals' desoximetasone topical generic under an Original Application (ANDA 208163).

• FDA approval · 2017-01-09
  FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)

  FDA approved Lupin Pharmaceuticals' desoximetasone as a generic topical corticosteroid under an original ANDA.

• FDA approval · 2017-01-06
  FDA Approved: DESOXIMETASONE — Original Application (Saptalis Pharmaceuticals, LLC.)

  The FDA approved an original ANDA application from Saptalis Pharmaceuticals for a desoximetasone topical product, a generic corticosteroid f…

• FDA approval · 2016-12-20
  FDA Approved: TREXALL — Supplemental Application (Teva Women's Health, Inc.)

  FDA approved a supplemental application for TREXALL (methotrexate) from Teva Women's Health, Inc.

• FDA approval · 2016-12-12
  FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)

  FDA approved Lupin Pharmaceuticals' generic desoximetasone topical (original application) for relief of inflammatory and pruritic manifestat…

• FDA approval · 2016-11-07
  FDA Approved: DESOXIMETASONE — Original Application (Actavis Pharma, Inc.)

  FDA approved Actavis Pharma's generic desoximetasone under an original ANDA, enabling a new topical corticosteroid product to reach the mark…

• FDA approval · 2016-10-26
  FDA Approved: TRIAMCINOLONE ACETONIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA granted approval of a supplemental application for Triamcinolone Acetonide submitted by Sun Pharmaceutical Industries, Inc., resulting i…

• FDA approval · 2016-10-21
  FDA Approved: FLUOCINOLONE ACETONIDE TOPICAL — Original Application (Actavis Pharma, Inc.)

  FDA approved a generic fluocinonide acetonide topical product under an original application from Actavis Pharma, Inc.

• FDA approval · 2016-08-05
  FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved the Original Application (ANDA) for Triamcinolone Acetonide, a generic product manufactured by Glenmark Pharmaceuticals Inc., U…

• FDA approval · 2016-07-28
  FDA Approved: PSORCON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for PSORCON (diflorasone diacetate) filed by Sun Pharmaceutical Industries, likely updating labeling…

• FDA approval · 2016-07-22
  FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approves Glenmark's generic Triamcinolone Acetonide under Original Application (ANDA 206379) for topical corticosteroid use in inflammat…